id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-N-0313-0003,FDA,FDA-2004-N-0313,Draft Risk Assessment of Streptogramin Resistance in Enterococcus faecium Attributable to the Use of Streptogramins in Animals; Extension of Comment Period,Notice,Notice of Extension,2005-01-06T00:00:00Z,2005,1,2005-01-05T05:00:00Z,2005-02-24T04:59:59Z,2025-05-06T21:49:56Z,05-111,0,0,0900006480472f32
FDA-2004-N-0313-0001,FDA,FDA-2004-N-0313,Draft Risk Assessment of Streptogramin Resistance in Enterococcus faecium Attributable to the Use of Streptogramins in Animals; Availability,Notice,Notice of Data Availability,2004-11-24T00:00:00Z,2004,11,2004-11-24T05:00:00Z,2005-01-25T04:59:59Z,2025-05-09T01:17:11Z,04-25979,0,0,0900006480472f2e
FDA-2004-N-0313-0002,FDA,FDA-2004-N-0313,Risk Assessment of Streptogramin Resistance in Enterococcus faecium Attributable to the Use of Streptogramins in Animals - “Virginiamycin Risk Assessment” - Draft for Comment,Supporting & Related Material,Background Material,2004-11-24T00:00:00Z,2004,11,,,2025-05-06T21:54:53Z,,0,0,0900006480472f2f